scispace - formally typeset
J

Johanna M. Seddon

Researcher at University of Massachusetts Medical School

Publications -  354
Citations -  35772

Johanna M. Seddon is an academic researcher from University of Massachusetts Medical School. The author has contributed to research in topics: Macular degeneration & Population. The author has an hindex of 97, co-authored 347 publications receiving 33646 citations. Previous affiliations of Johanna M. Seddon include Tufts University & University of Massachusetts Amherst.

Papers
More filters
Journal ArticleDOI

Dietary Carotenoids, Vitamins A, C, and E, and Advanced Age-Related Macular Degeneration

TL;DR: Increasing the consumption of foods rich in certain carotenoids, in particular dark green, leafy vegetables, may decrease the risk of developing advanced or exudative AMD, the most visually disabling form of macular degeneration among older people.
Journal ArticleDOI

Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration

TL;DR: Identification of ABCR alterations will permit presymptomatic testing of high-risk individuals and may lead to earlier diagnosis of AMD and to new strategies for prevention and therapy.
Journal ArticleDOI

Seven new loci associated with age-related macular degeneration

Lars G. Fritsche, +185 more
- 01 Apr 2013 - 
TL;DR: A collaborative genome-wide association study, including >17,100 advanced AMD cases and >60,000 controls of European and Asian ancestry, identifies 19 loci associated at P < 5 × 10−8, which show enrichment for genes involved in the regulation of complement activity, lipid metabolism, extracellular matrix remodeling and angiogenesis.
Journal ArticleDOI

Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19.

TL;DR: In this article, the authors describe the association of demographic, behavioral, medical, and non-retinal ocular factors with the incidence of neovascular age-related macular degeneration (AMD) and central geographic atrophy (CGA) in the AREDS, a randomized trial of antioxidants and zinc supplementation prophylaxis for development of advanced AMD.
Journal ArticleDOI

Common variation in three genes, including a noncoding variant in CFH , strongly influences risk of age-related macular degeneration

TL;DR: A previously unrecognized common, noncoding variant in CFH, the gene encoding complement factor H, that substantially increases the influence of this locus on AMD is identified, and four other previously reported common alleles in three genes are strongly replicated.